The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ.

Breast Cancer Research and Treatment
Abdulbaqi Al-KawazEmad A Rakha

Abstract

Impaired DNA repair mechanism is one of the cancer hallmarks. Flap Endonuclease 1 (FEN1) is essential for genomic integrity. FEN1 has key roles during base excision repair (BER) and replication. We hypothesised a role for FEN1 in breast cancer pathogenesis. This study aims to assess the role of FEN1 in breast ductal carcinoma in situ (DCIS). Expression of FEN1 protein was evaluated in a large (n = 1015) well-characterised cohort of DCIS, comprising pure (n = 776) and mixed (DCIS coexists with invasive breast cancer (IBC); n = 239) using immunohistochemistry (IHC). FEN1 high expression in DCIS was associated with aggressive and high-risk features including higher nuclear grade, larger tumour size, comedo type necrosis, hormonal receptors negativity, higher proliferation index and triple-negative phenotype. DCIS coexisting with invasive BC showed higher FEN1 nuclear expression compared to normal breast tissue and pure DCIS but revealed significantly lower expression when compared to the invasive component. However, FEN1 protein expression in DCIS was not an independent predictor of local recurrence-free interval. High FEN1 expression is linked to features of aggressive tumour behaviour and may play a role in the direct progressio...Continue Reading

References

Apr 22, 1999·The Journal of Pathology·E WarbrickP A Hall
Feb 17, 2000·Journal of the National Cancer Institute·F M WaldmanB M Ljung
Apr 20, 2000·Biochimica Et Biophysica Acta·I S KimS Y Lee
May 1, 2001·Nature Medicine·K L NathansonK N Nathanson
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Melanie KucherlapatiRaju Kucherlapati
Mar 1, 2003·Nature Genetics·Allan BalmainBruce Ponder
Mar 26, 2003·The American Journal of Pathology·Christine A Iacobuzio-DonahueMichael Goggins
Apr 8, 2004·Journal of the National Cancer Institute·Sandra M SwainNorman Wolmark
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ArpinoC K Osborne
Jun 1, 2005·Cancer Letters·Alexander KrauseAlain Puisieux
May 10, 2007·Molecular Endocrinology·Jennifer R Schultz-NortonAnn M Nardulli
Jun 26, 2007·Nature Medicine·Li ZhengBinghui Shen
Nov 18, 2008·Molecular Cancer Research : MCR·Purnima SinghBinghui Shen
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Elizabeth H HammondAntonio C Wolff
Aug 24, 2010·Nature Chemical Biology·Zhigang GuoBinghui Shen
Oct 23, 2010·Molecular Cell·Alberto Ciccia, Stephen J Elledge
May 10, 2011·Journal of Cancer·Sara A Lari, Henry M Kuerer
Jan 9, 2014·Radiation Research·Constantinos G Broustas, Howard B Lieberman
Jun 24, 2014·Nature Reviews. Molecular Cell Biology·Jurgen A MarteijnJan H J Hoeijmakers
Dec 10, 2014·Journal of Clinical Pathology·Emad A RakhaUNKNOWN National Coordinating Committee for Breast Pathology
Jan 13, 2015·Women's Health·Ying LiuGraham A Colditz
Feb 1, 2015·Environmental Health : a Global Access Science Source·Erika GarciaPeggy Reynolds
May 6, 2015·Expert Opinion on Drug Metabolism & Toxicology·Jasmeet C Singh, Stuart M Lichtman
Sep 27, 2015·Cancer Causes & Control : CCC·Katie M O'BrienClarice R Weinberg
Nov 18, 2016·EBioMedicine·Lingfeng HeZhigang Guo
Dec 31, 2016·Pathology·Reem AliHelen E Bryant
Feb 12, 2017·Oncotarget·Chandrasekhar KatheraZhigang Guo
Apr 30, 2017·Breast Cancer Research and Treatment·Eleni ChrysanthouAbhik Mukherjee

❮ Previous
Next ❯

Software Mentioned

GenExMiner
- GenExMiner
bc
tile Bioinformatics
tile

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.